1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with omega-n-methylarginine in 27 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 4,411 | 344 | 336 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | omega-n-methylarginine (IC50) |
|---|---|---|---|
| Neutrophil elastase | Homo sapiens (human) | 0.3 | |
| Proteinase-activated receptor 1 | Homo sapiens (human) | 0.0018 | |
| Nitric oxide synthase, endothelial | Bos taurus (cattle) | 7 | |
| Nitric oxide synthase, endothelial | Homo sapiens (human) | 2.9489 | |
| Nitric oxide synthase, brain | Homo sapiens (human) | 3.3983 | |
| Nitric oxide synthase, brain | Rattus norvegicus (Norway rat) | 7.5 | |
| Nitric oxide synthase, inducible | Mus musculus (house mouse) | 2.3 | |
| Nitric oxide synthase, inducible | Homo sapiens (human) | 2.9252 | |
| Collagenase 3 | Homo sapiens (human) | 0.3 | |
| Nitric oxide synthase, brain | Mus musculus (house mouse) | 4.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 18 (66.67) | 18.2507 |
| 2000's | 9 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boughton-Smith, NK; Deakin, AM; Whittle, BJ | 1 |
| de Nucci, G; Mitchell, JA; Vane, JR; Warner, TD | 1 |
| Shiga, T; Yoshikawa, D | 1 |
| Bailly, C; Imbert-Teboul, M; Néant, F | 1 |
| Alonso, A; Bosca, L; Crespo, MS; Garcia Rodriguez, MC; Steil, AA | 1 |
| Adler, KB; Choe, NH; Fischer, BM; Li, H; Wright, DT | 1 |
| Martin, D; Nadler, JV; Peterson, CL; Thompson, MA | 1 |
| Caplan, MS; Hedlund, E; Hill, N; MacKendrick, W | 1 |
| Filep, JG; Földes-Filep, E | 1 |
| Green, PG; Heller, PH; Levine, JD; Luo, J | 1 |
| Durán, WN; Fallek, SR; Hobson, RW; Noel, AA | 1 |
| Durán, WN; Kim, D; Minnicozzi, M; Oshiro, H; Quardt, SM; Ramírez, MM | 1 |
| Handa, RK; Strandhoy, JW | 1 |
| Howard, KM; Mustafa, SB; Olson, MS | 1 |
| Bindoni, M; Cardile, V; Jiang, X; Renis, M | 1 |
| Baskin, SI; Lempka, JC; Nealley, EW | 1 |
| Berón de Astrada, M; Chaud, MA; Franchi, AM; Gimeno, MF | 1 |
| Kula, P; Kurmanowska, Z; Nowak, D; Stolarek, R | 1 |
| Ahmed, A; Ahmed, Z; Dearn, S; Eggo, MC; Lewis, A; Rahman, M | 1 |
| Foreman, JC; Maggs, JR; Turner, PJ | 1 |
| Calcerrada, MC; Catalan, RE; Martinez, AM | 1 |
| Bussolati, B; Camussi, G; Mariano, F; Migliori, M | 1 |
| Bussolati, B; Camussi, G; Mariano, F; Migliori, M; Russo, S; Triolo, G | 1 |
| Castranova, V; He, P; Schwegler-Berry, D; Zhu, L | 1 |
| Alloatti, G; Altruda, F; Azzolino, O; Barberis, L; Bedendi, I; Bosco, O; Del Sorbo, L; Hirsch, E; Levi, R; Malan, D; Marcantoni, A; Montrucchio, G; Penna, C; Wymann, M | 1 |
| Slomiany, A; Slomiany, BL | 1 |
| He, P; Zhu, L | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and omega-n-methylarginine
| Article | Year |
|---|---|
Induction by inhibitors of nitric oxide synthase of hyperresponsiveness in the human nasal airway.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Bradykinin Receptor Antagonists; Bronchial Hyperreactivity; Cross-Over Studies; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Humans; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor; Receptor, Bradykinin B2 | 2000 |
26 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and omega-n-methylarginine
| Article | Year |
|---|---|
Actions of nitric oxide on the acute gastrointestinal damage induced by PAF in the rat.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Blood Pressure; Capillary Permeability; Endotoxins; Escherichia coli; Intestine, Small; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Penicillamine; Platelet Activating Factor; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; Stomach; Vasodilator Agents | 1992 |
Alkaline buffers release EDRF from bovine cultured aortic endothelial cells.
Topics: Animals; Arginine; Buffers; Cattle; Cells, Cultured; Cyclohexanones; Endothelium, Vascular; Epoprostenol; Hydrogen-Ion Concentration; Lipoprotein Lipase; Nitric Oxide; omega-N-Methylarginine; Platelet Activating Factor; Pyrimidinones; Thiazoles | 1991 |
Platelet-activating factor-induced loss of vascular responsiveness to noradrenaline in pithed rats: involvement of nitric oxide.
Topics: Analysis of Variance; Animals; Arginine; Cyclooxygenase Inhibitors; Decerebrate State; Enzyme Inhibitors; Indomethacin; Male; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; omega-N-Methylarginine; Platelet Activating Factor; Rats; Rats, Wistar; Vasomotor System | 1995 |
Cyclic guanosine monophosphate is the mediator of platelet-activating factor inhibition on transport by the mouse kidney thick ascending limb.
Topics: Amino Acid Oxidoreductases; Animals; Arginine; Calcium; Chlorides; Cyclic AMP; Cyclic GMP; In Vitro Techniques; Isoquinolines; Kidney Medulla; Kinetics; Loop of Henle; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Parathyroid Hormone; Platelet Activating Factor; Protein Kinase C; Time Factors; Vasopressins | 1994 |
Platelet-activating factor: the effector of protein-rich plasma extravasation and nitric oxide synthase induction in rat immune complex peritonitis.
Topics: Amino Acid Oxidoreductases; Analysis of Variance; Animals; Antibody Formation; Arginine; Arthus Reaction; Blotting, Northern; Cells, Cultured; Enzyme Induction; Extravasation of Diagnostic and Therapeutic Materials; Leucine; Male; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peritoneal Cavity; Peritonitis; Phagocytes; Piperazines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Specific Pathogen-Free Organisms | 1995 |
Hypersecretion of mucin in response to inflammatory mediators by guinea pig tracheal epithelial cells in vitro is blocked by inhibition of nitric oxide synthase.
Topics: Animals; Arginine; Cells, Cultured; Enzyme Inhibitors; Guinea Pigs; Histamine; Inflammation Mediators; Mucins; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor; Secretory Rate; Superoxides; Trachea; Tumor Necrosis Factor-alpha | 1995 |
Modulation of glutamate and aspartate release from slices of hippocampal area CA1 by inhibitors of arachidonic acid metabolism.
Topics: Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Arginine; Aspartic Acid; Female; Flavanones; Flavonoids; gamma-Aminobutyric Acid; Glutamates; Hippocampus; In Vitro Techniques; Indoles; Indomethacin; Masoprocol; omega-N-Methylarginine; Platelet Activating Factor; Potassium; Prostaglandin-Endoperoxide Synthases; Quinacrine; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Taurine | 1995 |
The role of endogenous nitric oxide and platelet-activating factor in hypoxia-induced intestinal injury in rats.
Topics: Animals; Arginine; Hypoxia; Intestines; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Peroxidase; Platelet Activating Factor; Rats; Rats, Sprague-Dawley | 1994 |
Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat.
Topics: Albumins; Animals; Arginine; Blood Pressure; Capillary Permeability; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Platelet Activating Factor; Rats; Rats, Wistar | 1993 |
Neurogenic and non-neurogenic mechanisms of plasma extravasation in the rat.
Topics: Animals; Arginine; Blood Physiological Phenomena; Bradykinin; Dose-Response Relationship, Drug; Joints; Male; Models, Biological; omega-N-Methylarginine; Oxidopamine; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical; Time Factors | 1993 |
Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation.
Topics: Animals; Arginine; Capillary Permeability; Cheek; Cricetinae; Cromolyn Sodium; Dextrans; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Histamine; Inflammation; Macrophage-1 Antigen; Male; Mast Cells; Mesocricetus; Microcirculation; Microscopy, Video; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor | 1995 |
Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.
Topics: Animals; Arginine; Capillary Permeability; Cheek; Cricetinae; Male; Mesocricetus; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor; Signal Transduction | 1995 |
Nitric oxide mediates the inhibitory action of platelet-activating factor on angiotensin II-induced renal vasoconstriction, in vivo.
Topics: Angiotensin II; Animals; Arginine; Blood Pressure; Enzyme Inhibitors; Kidney; Linear Models; Male; Nitric Oxide; omega-N-Methylarginine; Platelet Activating Factor; Rats; Rats, Wistar; Vasoconstriction | 1996 |
Platelet-activating factor augments lipopolysaccharide-induced nitric oxide formation by rat Kupffer cells.
Topics: Animals; Arginine; Biological Transport, Active; Cells, Cultured; Cyclic GMP; Cycloheximide; Dactinomycin; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; Kinetics; Kupffer Cells; Lipopolysaccharides; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor; Protein Synthesis Inhibitors; Rats; RNA, Messenger; Shock, Septic | 1996 |
Effects of ether lipid 1-O-octadecyl-2-methoxy-rac-glycero- 3-phosphocholine and its analogs PAF and CPAF on the release of nitric oxide in primary cultures of rat astrocytes.
Topics: Animals; Antineoplastic Agents; Astrocytes; Azepines; Cells, Cultured; Citrulline; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Immunohistochemistry; Lipopolysaccharides; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Stimulation, Chemical; Thienopyridines; Triazoles | 1996 |
The effects of EDRF/NO releasers or calcium ionophore A23187 on cyanide toxicity in mice.
Topics: Animals; Bradykinin; Calcimycin; Carbachol; Cyanides; Hydralazine; Ionophores; Lethal Dose 50; Male; Mice; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor; Seizures; Substance P; Survival Rate | 1996 |
Nitric oxide mediates platelet-activating factor stimulatory action on uterine prostaglandin production.
Topics: Animals; Arachidonic Acid; Citrulline; Cyclooxygenase Inhibitors; Dinoprostone; Embryo Implantation; Enzyme Inhibitors; Female; Gestational Age; Indomethacin; Isometric Contraction; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor; Pregnancy; Prostaglandins; Rats; Rats, Wistar; Uterus | 1998 |
Effect of various agonists on nitric oxide generation by human polymorphonuclear leukocytes.
Topics: Concanavalin A; Enzyme Inhibitors; Humans; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Platelet Activating Factor; Tetradecanoylphorbol Acetate | 1998 |
Activation of platelet-activating factor (PAF) receptor stimulates nitric oxide (NO) release via protein kinase C-alpha in HEC-1B human endometrial epithelial cell line.
Topics: Azepines; Calcium; Cell Line; Endometrium; Enzyme Activation; Epithelial Cells; Female; Humans; Indoles; Infertility, Female; Isoenzymes; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Platelet Activating Factor; Platelet Membrane Glycoproteins; Protein Kinase C; Protein Kinase C-alpha; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Signal Transduction; Triazoles | 2000 |
PAF-stimulated protein tyrosine phosphorylation in hippocampus: involvement of NO synthase.
Topics: Animals; Hippocampus; In Vitro Techniques; Kinetics; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Phosphoproteins; Phosphorylation; Phosphotyrosine; Platelet Activating Factor; Rats; Rats, Wistar | 2002 |
Nitric oxide/platelet activating factor cross-talk in mesangial cells modulates the interaction with leukocytes.
Topics: Cell Adhesion; Cell Communication; Cells, Cultured; Enzyme Inhibitors; Humans; Intercellular Adhesion Molecule-1; Kidney Glomerulus; Leukocytes, Mononuclear; Monocytes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor | 2002 |
Platelet-activating factor synthesis by neutrophils, monocytes, and endothelial cells is modulated by nitric oxide production.
Topics: Adult; Arginine; Cells, Cultured; Cyclic GMP; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Humans; Lipopolysaccharides; Monocytes; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Platelet Activating Factor; Stereoisomerism; Tumor Necrosis Factor-alpha | 2003 |
Internalization of caveolin-1 scaffolding domain facilitated by Antennapedia homeodomain attenuates PAF-induced increase in microvessel permeability.
Topics: Animals; Antennapedia Homeodomain Protein; Capillary Permeability; Caveolin 1; Caveolins; Endothelium, Vascular; Enzyme Inhibitors; Female; Homeodomain Proteins; Microcirculation; Microscopy, Electron; Microscopy, Fluorescence; Nuclear Proteins; omega-N-Methylarginine; Platelet Activating Factor; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Transcription Factors | 2004 |
Phosphoinositide 3-kinase gamma-deficient hearts are protected from the PAF-dependent depression of cardiac contractility.
Topics: Animals; Azepines; Class Ib Phosphatidylinositol 3-Kinase; Female; In Vitro Techniques; Isoenzymes; Mice; Mice, Knockout; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Perfusion; Phosphatidylinositol 3-Kinases; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction; Triazoles | 2003 |
Platelet-activating factor mediates Porphyromonas gingivalis lipopolysaccharide interference with salivary mucin synthesis via phosphatidylinositol 3-kinase-dependent constitutive nitric-oxide synthase activation.
Topics: Amidines; Androstadienes; Animals; Apoptosis; Benzylamines; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Ginkgolides; Glucosamine; Lactones; Lipopolysaccharides; Mucins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Platelet Activating Factor; Porphyromonas gingivalis; Rats; Rats, Sprague-Dawley; Saliva; Salivary Glands; Sublingual Gland; Tritium; Tumor Necrosis Factor-alpha; Up-Regulation; Wortmannin | 2004 |
Platelet-activating factor increases endothelial [Ca2+]i and NO production in individually perfused intact microvessels.
Topics: Animals; Calcium; Cytoplasm; Endothelium, Vascular; Mesenteric Veins; Microcirculation; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Platelet Activating Factor; Rats; Venules | 2005 |